Selfapy has placed its fifth active app in the DiGA directory: Selfapy’s online course for chronic pain – in cooperation with the pharmaceutical company Pfizer. The app supports patients’ self-regulation skills in dealing with pain. However, the application for cancer patients CANKADO PRO-React Onco was removed from the DiGA list, as the positive treatment effect could not be proven during the trial period. Despite the new additions, there are still 45 DiGAs available in the DiGA directory.
LINK